# BiDil

NDC: 24338-010
Generic name: Hydralazine hydrochloride and Isosorbide dinitrate
Labeler / Manufacturer: Azurity Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20121205

FDA application: NDA020727

## Active ingredients

- HYDRALAZINE HYDROCHLORIDE: 37.5 mg/1
- ISOSORBIDE DINITRATE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24338-010"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24338-010
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1e63cd5-d1e4-4af5-bad5-1ad41ea46b00